SI
AMAG

Sofinnova Investments’s AMAG Pharmaceuticals AMAG Stock Holding History

Sofinnova Investments’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-142,511
Closed -$2.78M – 71
2018
Q2 		$2.78M Buy
+142,511
New +$3.15M 0.31% 49

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sofinnova Investments's AMAG Position: Q3 2018 in Review

Sofinnova Investments sold out of AMAG Pharmaceuticals (AMAG) in Q3 2018, closing a stake of 142,511 shares — an estimated $2.78M sold.

Sofinnova Investments first reported a position in AMAG in Q2 2018 and held it in 1 quarter. The position peaked at $2.78M in Q2 2018. 182 funds tracked by Wall St. Rank hold AMAG as of Q3 2018.

  • Sofinnova Investments reported no remaining AMAG Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Sofinnova Investments sold 142,511 AMAG Pharmaceuticals shares in Q3 2018, an estimated $2.78M.
  • Sofinnova Investments first reported a position in AMAG Pharmaceuticals in Q2 2018 and held it in 1 quarter.
  • Sofinnova Investments's AMAG Pharmaceuticals position peaked at $2.78M in Q2 2018.
  • 182 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2018.

Based on Sofinnova Investments's 13F filing for Q3 2018, filed 15 Nov 2018.